Showing 1,801 - 1,820 results of 1,890 for search '"Type 2 diabetes"', query time: 0.08s Refine Results
  1. 1801

    Exenatide with Metformin Ameliorated Visceral Adiposity and Insulin Resistance by Xuan Du, Wen Lu, Zijun Lu, Xinyu Shao, Chunhong Hu, Bimin Shi

    Published 2018-01-01
    “…Exenatide is an ideal treatment for obese type 2 diabetic patients in the aspect of adipose tissue distribution. …”
    Get full text
    Article
  2. 1802

    Insulin Detemir Causes Lesser Weight Gain in Comparison to Insulin Glargine: Role on Hypothalamic NPY and Galanin by Mohammad Ishraq Zafar, Cuining Hu, Danfeng Liu, Raja Adeel Shafqat, Feng Gao

    Published 2014-01-01
    “…Insulin detemir decreased food intake in type 2 diabetic rats, which led to reduced weight gain when compared to insulin glargine treatment. …”
    Get full text
    Article
  3. 1803

    Nonalcoholic Fatty Hepatitis: An Important Clinical Condition by Samuel W. French, Leslie B. Eidus, J. Freeman

    Published 1989-01-01
    “…The roles of alcohol, obesity and type II diabetes are stressed where inhibition of fatty acid oxidation by the liver is the basic defect in metabolism leading to fatty change, balloon degeneration and Mallory body formation. …”
    Get full text
    Article
  4. 1804

    Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy by Ruixia Ma, Ying Wang, Yan Xu, Rui Wang, Xianghua Wang, Ning Yu, Minghui Li, Yan Zhou

    Published 2021-01-01
    “…The purpose of this study was to investigate the potential mechanism of podocyte protection by tacrolimus in a type 2 diabetic mellitus (T2DM) rat model and in immortalized mouse podocytes (MPC5). …”
    Get full text
    Article
  5. 1805

    Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol by S. Serge Barold, Scott Upton

    Published 2018-01-01
    “…This report describes the occurrence of asymptomatic hyperkalemia induced by the sequential administration of metoprolol and carvedilol in an 81-year-old man with type II diabetes and stable stage III renal insufficiency. …”
    Get full text
    Article
  6. 1806

    Hyperglycemia and Endothelial Dysfunction in Atherosclerosis: Lessons from Type 1 Diabetes by Steven Daniel Funk, Arif Yurdagul, A. Wayne Orr

    Published 2012-01-01
    “…Some of this confusion derives from studies in type 2 diabetics where multiple components of metabolic syndrome show proatherosclerotic effects independent of underlying diabetes. …”
    Get full text
    Article
  7. 1807

    An Update on Inflamm-Aging: Mechanisms, Prevention, and Treatment by Shijin Xia, Xinyan Zhang, Songbai Zheng, Ramin Khanabdali, Bill Kalionis, Junzhen Wu, Wenbin Wan, Xiantao Tai

    Published 2016-01-01
    “…Increasing evidence indicates that inflamm-aging is intensively associated with many aging diseases, such as Alzheimer’s disease, atherosclerosis, heart disease, type II diabetes, and cancer. Mounting studies have focused on the role of inflamm-aging in disease progression and many advances have been made in the last decade. …”
    Get full text
    Article
  8. 1808

    Lactobacillus gasseri Causing Bilateral Empyema by Angela Esquibel, Ala S. Dababneh, Bharath Raj Palraj

    Published 2017-01-01
    “…This is a case of a 49-year-old male with previously undiagnosed type two diabetes mellitus who presented with a 3-month history of cough and was found to have right sided Lactobacillus gasseri empyema for which he underwent video-assisted thoracoscopic surgery (VATS) with chest tube placement. …”
    Get full text
    Article
  9. 1809

    Cross-Talk between PPARγ and Insulin Signaling and Modulation of Insulin Sensitivity by Anna Leonardini, Luigi Laviola, Sebastio Perrini, Annalisa Natalicchio, Francesco Giorgino

    Published 2009-01-01
    “…PPARγ activation in type 2 diabetic patients results in a marked improvement in insulin and glucose parameters, resulting from an improvement of whole-body insulin sensitivity. …”
    Get full text
    Article
  10. 1810

    Updating Experimental Models of Diabetic Cardiomyopathy by J. Fuentes-Antrás, B. Picatoste, A. Gómez-Hernández, J. Egido, J. Tuñón, Ó. Lorenzo

    Published 2015-01-01
    “…Inflammation, hypertrophy, fibrosis, steatosis, and apoptosis in the myocardium have been studied in numerous diabetic experimental models in animals, mostly rodents. Type I and type II diabetes were induced by genetic manipulation, pancreatic toxins, and fat and sweet diets, and animals recapitulate the main features of human diabetes and related cardiomyopathy. …”
    Get full text
    Article
  11. 1811

    Mathematical modelling and simulation analysis of a modified Butterworth van Dyke circuit model for non‐invasive diabetes detection by Srinivasan Lekha, Suchetha Manikandan

    Published 2017-11-01
    “…This study studies these characteristics and evaluates the behaviour of the sensor in the presence of various acetone concentrations in breath sample for healthy, type 1 and type 2 diabetic subjects.…”
    Get full text
    Article
  12. 1812

    Exercise and the Cardiovascular System by Saeid Golbidi, Ismail Laher

    Published 2012-01-01
    “…There are alarming increases in the incidence of obesity, insulin resistance, type II diabetes, and cardiovascular disease. The risk of these diseases is significantly reduced by appropriate lifestyle modifications such as increased physical activity. …”
    Get full text
    Article
  13. 1813

    Primary Carcinoma in Squamous Cells of the Gallbladder by Javier Martínez Navarro, Virgen Yazmín Martínez Navarro, Lisanka Fumero Roldán

    Published 2018-09-01
    “…A case of an 81 year old patient is presented, with antecedents of type II diabetes mellitus and high blood pressure on permanent drug treatment. …”
    Get full text
    Article
  14. 1814

    An Immunomodulatory Device Improves Insulin Resistance in Obese Porcine Model of Metabolic Syndrome by Angela J. Westover, Kimberly A. Johnston, Deborah A. Buffington, H. David Humes

    Published 2016-01-01
    “…These results allow for the planning of first-in-man studies in obese type 2 diabetic patients.…”
    Get full text
    Article
  15. 1815

    Catecholamines Mediate Multiple Fetal Adaptations during Placental Insufficiency That Contribute to Intrauterine Growth Restriction: Lessons from Hyperthermic Sheep by D. T. Yates, A. S. Green, S. W. Limesand

    Published 2011-01-01
    “…These adrenergically influenced adaptive responses promote in utero survival but also cause asymmetric intrauterine growth restriction and small-for-gestational-age infants that are at greater risk for serious metabolic disorders throughout postnatal life, including obesity and type II diabetes.…”
    Get full text
    Article
  16. 1816

    Height Constitutes an Important Predictor of Mortality in End-Stage Renal Disease by Tsuneo Takenaka, Takahiko Sato, Hitoshi Hoshi, Nobutaka Kato, Keita Sueyoshi, Masahiro Tsuda, Yusuke Watanabe, Hiroshi Takane, Yoichi Ohno, Hiromichi Suzuki

    Published 2011-01-01
    “…Fifty two hypertensive patients with type 2 diabetic nephropathy receiving hemodialysis and 52 patients with nondiabetic nephropathy were enrolled. …”
    Get full text
    Article
  17. 1817

    Implementation of medication management services at the primary healthcare level – a pilot study by Brajković Andrea, Mucalo Iva, Vidović Toni, Gonzaga Mariana Martins, Nascimento Do, Balenović Antonija, Protrka Ino, De Oliveira Djenane Ramalho

    Published 2019-12-01
    “…Multiple regression analysis showed that type 2 diabetic patients (p = 0.025) and patients using five or more medications (p = 0.011) should be prioritized to receive CMM services as potentially they have a higher number of DTPs, and could, therefore, obtain a greater benefit from the service.…”
    Get full text
    Article
  18. 1818

    PREVALENCE OF RAMADAN AND FASTING RELATED DIABETICCOMPLICATIONS AMONG DIABETIC PATIENTS by Aisha Noreen et al

    Published 2024-09-01
    “…Adjusting of drug regimen along with control over the diet and daily activities composed a Ramadan 3D Triangle through which a proper supervision and education came in to being concluding that few of the type I and most of the type II diabetes mellitus patients who wanted to fast could carefully manage it. …”
    Get full text
    Article
  19. 1819

    Rare Case of Aspergillus ochraceus Osteomyelitis of Calcaneus Bone in a Patient with Diabetic Foot Ulcers by Farhang Babamahmoodi, Tahereh Shokohi, Fatemeh Ahangarkani, Mojtaba Nabili, Elham Afzalian Ashkezari, Sosan Alinezhad

    Published 2015-01-01
    “…The case was a 68-year-old male with a history of type II diabetes for 2 years. The patient had two ulcers on the right heel bones for the past 6 months with no significant improvement. …”
    Get full text
    Article
  20. 1820

    The Threshold of the Severity of Diabetic Retinopathy below Which Intensive Glycemic Control Is Beneficial in Diabetic Patients: Estimation Using Data from Large Randomized Clinica... by Yuqi Liu, Juan Li, Jinfang Ma, Nanwei Tong

    Published 2020-01-01
    “…However, these are realized only if the HbA1c in type 1 or type 2 diabetic patients is reduced at least by 0.8% versus the control group or it is reduced to <7% and >3 years of intensive glucose control is required. …”
    Get full text
    Article